Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus

Related articles

13 Nov 2018 : Clinical Research

Clinical Inertia in Type 2 Diabetes Patients in Primary Health Care Clinics in Central Bosnia

Marijan Marjanović, Davorka Vrdoljak, [...] Valerija Bralić Lang, Ozren Polašek, Vedran Đido, Marinka Kašćel Fišić, Ivanka Mađar Šimić, Danijela Dodig, Marina Radoš Perić - Show fewer authors

DOI: 10.12659/MSM.911286

02 Dec 2018 : Clinical Research

Long-Term Patterns of Antidiabetic Medication Use in Patients with Type 2 Diabetes

Yang Xu, Zhirong Yang, [...] Hongbo Lin, Peng Shen, Haining Wang, Siyan Zhan - Show fewer authors

DOI: 10.12659/MSM.913603

01 May 2014 : Research paper

Differential pattern for regulating insulin secretion, insulin resistance, and lipid metabolism by osteocalcin in male and female T2DM patients

Xuefei Rui, Bei Xu, [...] Junlei Su, Chunping Pan, Chenyu Zhan, Bin Su, Hong Li, Jiying Wang, Hui Sheng, Shen Qu - Show fewer authors

DOI: 10.12659/MSM.890130

01 Dec 2012

Optimizing HgA1C and glucose monitoring frequency in patients with Type 2 diabetes

Juanita F. Bridges, Daniel Brignac, [...] Sequria Thomas, Carmen Kent, Marilyn Ogbuli, Jeanne Draper, Helen Rasumssen, Akane Daniels, Darlene Cook, Caroline Chartier, Lauren Brewer, Hani Mesak - Show fewer authors

DOI: 10.12659/MSM.883594

17 Sep 2014 : Original article

DPP-4 Inhibitors Improve Liver Dysfunction in Type 2 Diabetes Mellitus

Ippei Kanazawa, Ken-ichiro Tanaka, [...] Toshitsugu Sugimoto - Show fewer authors

DOI: 10.12659/MSM.890989

02 Dec 2014 : Review article

Dulaglutide: A Review of a New Glucagon-Like Peptide 1 Receptor Agonist for the Treatment of Type 2 Diabetes Mellitus

Mohamed Teleb, Ngamdu Sumayin, [...] Sarmad Said - Show fewer authors

DOI: 10.12659/MSRev.893152

21 Jun 2011

Modulating gut microbiota as an anti-diabetic mechanism of berberine

Junling Han, Huiling Lin, [...] Weiping Huang - Show fewer authors

DOI: 10.12659/MSM.881842

21 Jun 2011

Variation in KCNQ1 is associated with therapeutic response to sulphonylureas

Zbynek Schroner, Martina Dobrikova, [...] Lucia Klimcakova, Martin Javorsky, Jozef Zidzik, Miriam Kozarova, Terezia Hudakova, Ruzena Tkacova, Jan Salagovic, Ivan Tkac - Show fewer authors

DOI: 10.12659/MSM.881850

01 Dec 2007

Insulin treatment reduces pre-prandial plasma ghrelin concentrations in children with type 1 diabetes

Ambika Ashraf, Gail Mick, [...] Sreelatha Meleth, Xudong Wang, Kenneth McCormick - Show fewer authors

22 Dec 2005

The impact of rosiglitazone on cardiovascular responses and endurance during isometric exercise in patients with Type 2 Diabetes.

Jerrold Scott Petrofsky, Scott Lee

01 Jun 2005 : Original article

Gait characteristics in patients with type 2 diabetes; improvement after administration of rosiglitazone

Jerrold S. Petrofsky, Scott Lee, [...] Maria L. Cuneo - Show fewer authors

01 Dec 2005

The impact of the timing of Humalog Mix25 injections on blood glucose fluctuations in the postprandial period in elderly patients with type 2 diabetes.

Eduard Galic, Matjaz Vrtovec, [...] Velimir Bozikov, Maria Schwarzenhofer, Zvonko Milicevic - Show fewer authors

06 Jan 2004

The influence of glimepiride on the binding kinetics of insulin with its skeletal muscle and liver receptors in rats with short term and prolonged hyperglycemia induced by streptozotocin

Hanna Krauss, Marian Grzymisławski, [...] Jacek Koźlik, Przemysław Sosnowski, Jacek Piątek, Kinga Mikrut, Paweł Maćkowiak, Janusz Paluszak - Show fewer authors

01 Mar 2004

The metabolic effects of insulin and rosiglitazone combination therapy in Chinese Type 2 diabetic patients with nephropathy

Norman N. Chan, Peter C.Y. Tong, [...] Wing-Yee So, Wilson Y.S. Leung, Cherry K.P. Chiu, Juliana C.N. Chan - Show fewer authors